Julie Clayton

Chagas disease 101

It is 101 years since Carlos Chagas discovered the parasite responsible for the disease that now bears his name. What progress has been made since this discovery? Here Julie Clayton gives the low-down on Chagas disease.

RNA interference: The silent treatment

Biotech firms are vying to harness the potential of RNA interference. But will its impact be in finding new disease targets, or in RNA-based drugs? Julie Clayton investigates.

Cell biology: Close-up on cell biology

To define the workings of cellular structures and molecules requires cutting-edge technology not only in biology and biochemistry, but also now in nanotechnology. Hayley M. Birch and Julie Clayton report.

The promise of T. cruzi genomics

The publishing of the first Trypanosoma cruzi genome sequence was hailed as “a huge intellectual triumph”, but what has it delivered?

Clinical approval: Trials of an anticancer jab.

Two vaccines seem to be so effective in preventing HPV infection that mass vaccination has been introduced for girls. But will long-term studies show falls in cervical cancer?

The long and winding road.

Documentary makers can get as close to the war zones of disease as doctors and researchers — perhaps even closer. Julie Clayton and Declan Butler talk to Kevin Hull about his experiences.